StockData
Immuneering Corp logo

Immuneering Corp (IMRX) stock

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30
$3.50+0.04 (+1.16%)

Close on Nov 18, 2026Market cap $226.67MP/E –Yield –

Immuneering shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Immuneering's shares outstanding was 65M at Sep 30, 2026. For fiscal 2025 it was 44M, up 46.8% from the year before. The highest annual figure on record is 44M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202544M+46.8%
FY2024Dec 31, 202430M+5.5%
FY2023Dec 31, 202328M+7.7%
FY2022Dec 31, 202226M+93.8%
FY2021Dec 31, 202114M+175.0%
FY2020Dec 31, 20205M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202665M+63.1%
Q2 FY2026Jun 30, 202665M+79.8%
Q1 FY2026Mar 31, 202665M+82.0%
Q4 FY2025Dec 31, 202565M+108.7%
Q3 FY2025Sep 30, 202540M+32.9%
Q2 FY2025Jun 30, 202536M+21.4%
Q1 FY2025Mar 31, 202536M+21.0%
Q4 FY2024Dec 31, 202431M+6.1%
Q3 FY2024Sep 30, 202430M+2.0%
Q2 FY2024Jun 30, 202430M+3.5%
Q1 FY2024Mar 31, 202429M+11.1%
Q4 FY2023Dec 31, 202329M+10.9%
Q3 FY2023Sep 30, 202329M+10.9%
Q2 FY2023Jun 30, 202329M+8.6%
Q1 FY2023Mar 31, 202326M+0.3%
Q4 FY2022Dec 31, 202226M+1.1%
Q3 FY2022Sep 30, 202226M+44.3%
Q2 FY2022Jun 30, 202226M+432.6%
Q1 FY2022Mar 31, 202226M+432.5%
Q4 FY2021Dec 31, 202126M+427.5%
Q3 FY2021Sep 30, 202118M+269.4%
Q2 FY2021Jun 30, 20215M+0.1%
Q1 FY2021Mar 31, 20215M–
Q4 FY2020Dec 31, 20205M–
Q3 FY2020Sep 30, 20205M–
Q2 FY2020Jun 30, 20205M–

More Immuneering figures

See a number that looks wrong?